Suchergebnisse - "Delbarba, Elisa"

PubPharm (7)

1

GWAS defines pathogenic signaling pathways and prioritizes drug targets for IgA nephropathy

enthalten in: bioRxiv.org | 2021

von Kiryluk, K. | Sanchez-Rodriguez, E. | Zhou, X. | +185

2

Glomerulonefriti da tossici e farmaci

enthalten in: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia | 2021

von Delbarba, E. | Zappa, M. | Guerini, A. | +4

3

Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry

enthalten in: Journal of nephrology / Supplement | 2021

von Delbarba, E. | Econimo, L. | Dordoni, C. | +6

4

Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry

enthalten in: Journal of nephrology | 2021

von Delbarba, E. | Econimo, L. | Dordoni, C. | +6

5

Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry

enthalten in: Journal of nephrology | 2021

von Delbarba, E. | Econimo, L. | Dordoni, C. | +6

6

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy : The RI-CYCLO Randomized Trial

enthalten in: Journal of the American Society of Nephrology : JASN | 2021

von Scolari, F. | Delbarba, E. | Santoro, D. | +41

7

Rituximab in Membranous Nephropathy

enthalten in: Kidney international reports | 2021

von Gauckler, P. | Shin, J. | Alberici, F. | +76

CommentIn: Kidney Int. 2021 Sep;100(3):708-709. - PMID 34420663

1
[1]